|
|
Volumn 28, Issue 9, 1999, Pages 849-858
|
|
Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba;Interferon alfa en el tratamiento de la esclerosis multiple. Actualizacion y experiencia en Cuba
|
|
Author keywords
Alpha interferon; Beta interferon; Clinical trial; Copolymer I; Intravenous immunoglobulin; Multiple sclerosis
|
|
Indexed keywords
ALPHA INTERFERON;
ALPHAN1 INTERFERON;
ALPHAN3 INTERFERON;
BETA1A INTERFERON;
GLATIRAMER;
HEBERON ALFA R;
IMMUNOGLOBULIN;
INTERFERON BETA SERINE;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
UNCLASSIFIED DRUG;
ANTIVIRUS AGENT;
BETA INTERFERON;
LEUKOCYTE ANTIGEN;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CUBA;
DISEASE COURSE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRATHECAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MULTIPLE SCLEROSIS;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SUBCUTANEOUS DRUG ADMINISTRATION;
COMPARATIVE STUDY;
DRUG EFFECT;
IMMUNOLOGY;
NATURAL KILLER CELL;
REVIEW;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTIVIRAL AGENTS;
CUBA;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
INTERFERON-ALPHA;
INTERFERON-BETA;
KILLER CELLS, NATURAL;
MALE;
MULTIPLE SCLEROSIS;
TREATMENT OUTCOME;
|
|
EID: 0033124346
PISSN: 02100010
EISSN: None
Source Type: Journal
DOI: 10.33588/rn.2809.98329 Document Type: Article |
|
Times cited : (6)
|
|
References (4)
|
